$ATNM Catalysts: ph 3 Topline data from ad hoc analysis 2H20: 2)Ph 1 update Actimab-A + CLAG-M &amp; Explore pivotal trial design 2H20 3) Actimab-A+Venetoclax proof of concept data 2H20 4)Secure Gene TX partner 2H20 $jnj $nvs $sny $azn $abbv $amgn #pennystocks #OTCMarkets $cydy $bmy https://t.co/DtajbdHS6d